Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung Cancer

Name: Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung Cancer
Published: 2014
License: Public Domain

Sun Yat-sen University · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

carcinoma chemotherapy lung

lung, carcinoma, chemotherapy, egfr-tki resistance, bevacizumab, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung Cancer

Related documents